About This Comparison
Our Editorial Standards
This premature ejaculation provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, service areas, and verified customer reviews.
Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.
Premature Ejaculation Treatment in Delaware: Comparing All 5 Providers Available in 2026
5 PE treatment providers serve Delaware in 2026. Compare Hims, Ro, Strut, Promescent, and Mate on price, medications, and Delaware insurance coverage.
Which PE Treatment Providers Actually Operate in Delaware
Delaware's Insurance Parity Law and What It Means for Your PE Treatment Cost
Hims in Delaware: Best for Affordable Generic Prescriptions and Mobile-First Experience
Ro in Delaware: Top Choice for Insurance Navigation and Broader Treatment Access
Strut in Delaware: Highest Rated and Best for Custom Compounded Formulations
Promescent and Mate in Delaware: The PE Specialists Worth Knowing
PE Medications Available to Delaware Residents in 2026
What PE Treatment Actually Costs in Delaware Across All Five Providers
What's Different About Getting PE Treatment in Delaware Compared to Other States
Frequently Asked Questions
How many PE treatment providers are available in Delaware in 2026?
Five providers currently offer PE treatment to Delaware residents in 2026: Hims, Ro, Strut, Promescent, and Mate. UrWay Health, which appears in some national PE telehealth guides, does not operate in Delaware, so you won't be able to complete a consultation or receive prescriptions through that platform from a Delaware address. Of the five that do operate here, Strut and Hims are both rated 9.0 out of 10, Ro holds the top choice designation for its insurance navigation capabilities, and Promescent and Mate are the two PE specialists with a more focused product range. All five can prescribe or provide PE treatment to Delaware residents, but they differ significantly in medication type, pricing, and whether they work with insurance.
Does Delaware's insurance parity law cover online PE treatment consultations?
Yes. Delaware has full telehealth insurance parity, which legally requires commercial insurers to reimburse online consultations at the same rate as equivalent in-person visits. For PE treatment, this means the telehealth intake and consultation with a prescriber should be covered by your plan at your standard copay or cost-sharing rate if in-person sexual health or primary care visits are covered. The medication prescribed after the consultation is a separate pharmacy benefit question, but because sertraline and paroxetine are generic and inexpensive, your total cost can be quite low. Ro is the Delaware platform best set up to bill your insurance directly. Delaware Medicaid also has broader telehealth coverage than many states, which may apply if a PE consultation is handled within a primary care framework.
Can I get a sertraline prescription for PE through telehealth in Delaware?
Yes. Sertraline prescribed off-label for premature ejaculation is available to Delaware residents through all five platforms that offer prescription services, which includes Hims, Ro, Strut, Promescent, and Mate. Off-label prescribing is legal and common practice for PE treatment in the US, and Delaware has no state-level restrictions that would block a telehealth prescriber from writing this prescription remotely. The process involves completing an online intake form, a clinical review by a licensed prescriber, and if appropriate, a prescription sent to a pharmacy for delivery. Hims and Ro are the most straightforward paths to a sertraline prescription in Delaware, and because sertraline generics are extremely inexpensive, your out-of-pocket medication cost is typically very low regardless of which platform you use.
What is the cheapest way to get PE treatment in Delaware?
The cheapest realistic path for a Delaware resident in 2026 depends on your insurance status. If you have commercial insurance, route through Ro, use Delaware's parity law to get the consultation covered at your copay rate, and fill a generic sertraline prescription through your pharmacy benefit. Total monthly cost in that scenario can be under $15. If you're paying out of pocket without insurance, Hims offers the lowest subscription pricing for generic SSRI-based PE treatment in Delaware, typically under $30 per month. If you want to try something before committing to a prescription, Promescent's OTC benzocaine spray is available without a consultation and costs roughly $20 to $50 depending on quantity. Compounded formulations from Strut are the most expensive option but serve a different clinical need.
Is dapoxetine available to Delaware residents?
Dapoxetine is available to Delaware residents through compounding pharmacy channels, though it is not FDA-approved as a standalone drug in the United States the way it is in Europe and other markets. In practice, this means dapoxetine-based formulations can be prepared by a licensed compounding pharmacy and prescribed by a telehealth provider who determines it's clinically appropriate for you. Strut is the Delaware platform most positioned to provide this since it's backed by a compounding pharmacy and specializes in custom formulations. You would need to complete a telehealth consultation and have a prescriber determine that dapoxetine in a compounded form is the right choice for your situation. It is not available as a simple OTC purchase, and it won't show up as a standard generic at a retail pharmacy the way sertraline or paroxetine would.
Do I need a prescription for a benzocaine or lidocaine PE spray in Delaware?
No. Topical PE sprays containing benzocaine or lidocaine are classified as over-the-counter products and ship to Delaware without any prescription or telehealth consultation required. Promescent's FDA-cleared benzocaine spray is the most widely recognized product in this category and is available for direct purchase. Lidocaine sprays from various other brands are similarly OTC. You can order these to any Delaware address and start using them immediately. The main reason to eventually move toward a prescription treatment is if you find topical sprays insufficient for your situation or if you want a systemic medication approach. But for many Delaware residents, starting with an OTC spray is a low-friction, low-cost way to evaluate whether topical treatment works before committing to a prescription process.
Which Delaware PE provider is best for someone dealing with both PE and ED?
Strut is the strongest choice in Delaware for someone managing both premature ejaculation and erectile dysfunction simultaneously. Its compounding pharmacy backing allows it to create combination formulations that pair a PE medication, such as a low-dose SSRI or dapoxetine compound, with a PDE5 inhibitor like sildenafil or tadalafil in a single custom formula. That approach is clinically sensible because PE and ED often interact, and treating them in isolation with separate medications can create its own complications. Ro is also a reasonable choice for this situation given its broader clinical scope and provider visibility into your full health picture. Hims covers both conditions as well but with less compounding flexibility. Promescent and Mate are more narrowly focused and are less optimal for managing both conditions together.
How does the telehealth PE consultation process work for Delaware residents?
The process is similar across all five Delaware providers. You complete an online intake form covering your medical history, current medications, and PE symptoms. A licensed prescriber, who must be authorized to practice in Delaware, reviews your intake and either approves a prescription, requests more information, or schedules a video or async consultation depending on the platform. Hims and Strut use primarily asynchronous review, meaning the prescriber reviews your intake on their own schedule without a live video call. Ro may involve more direct clinical interaction depending on your case. Once a prescription is approved, it's sent to a pharmacy that ships directly to your Delaware address. Most Delaware residents receive medication within two to four days. The consultation itself typically takes 10 to 20 minutes of your time to complete.
Is Mate or Promescent better for PE treatment in Delaware?
It depends on what you're starting with. If you want to try a topical OTC treatment first without any consultation, Promescent is the better choice because its FDA-cleared benzocaine spray ships to Delaware without a prescription and has a strong track record. Promescent also offers prescription PE options, so you can escalate within the same platform if needed. Mate is better suited if you already know you want a prescription medication and prefer a simple, discreet online process without the topical-first framing. Mate's 8.3 out of 10 rating from 8,400 Delaware-eligible reviews suggests solid satisfaction for its focused use case. Promescent's 8.4 rating comes from a slightly larger base. For most Delaware residents starting from scratch, Promescent's OTC entry point makes it the more flexible starting option between the two.
Are there any Delaware-specific restrictions on getting PE medication through telehealth?
No meaningful state-specific restrictions apply to PE telehealth prescriptions in Delaware in 2026. Delaware does not impose additional limitations on remote prescribing for the medications commonly used to treat PE, including sertraline, paroxetine, and compounded dapoxetine formulations, beyond standard federal telehealth prescribing rules. The prescriber must be licensed to practice in Delaware and must conduct a proper clinical evaluation, which the intake process on all five platforms is designed to satisfy. Delaware's regulatory posture is generally favorable toward telehealth, and the state's parity and Medicaid expansion policies reflect a consistent push to make remote care as accessible as in-person care. If you have encountered information suggesting restrictions, it likely applies to a different state or to controlled substances, which none of the standard PE medications are.
Sources & References
Our comparisons are informed by official sources and regulatory guidelines. We encourage readers to verify information with authoritative sources.
- ISSM - Premature EjaculationInternational Society for Sexual Medicine clinical definition, diagnostic criteria, and treatment overview for premature ejaculation.
- PMC - PE Treatment Systematic Review2021 systematic review on PE treatment options: SSRIs, topical anesthetics (benzocaine, lidocaine), and combination therapy efficacy.
- NIH - Sildenafil (StatPearls)NIH clinical reference on sildenafil: mechanism of action as a PDE5 inhibitor, dosing, drug interactions, and safety.
- PMC - PE Management Review2021 narrative review on PE management including dapoxetine, off-label SSRIs, behavioral therapy, and combination treatment approaches.
- CCHP Telehealth Policy - DelawareDelaware state telehealth laws, online prescribing rules, and insurance reimbursement policies maintained by the Center for Connected Health Policy.
- America's Health Rankings - Obesity in DelawareDelaware adult obesity prevalence data from the CDC Behavioral Risk Factor Surveillance System.
- America's Health Rankings - Cardiovascular Health in DelawareDelaware cardiovascular disease prevalence, including heart attack, stroke, and coronary heart disease.
- NIDDK - Erectile DysfunctionNational Institute of Diabetes overview of erectile dysfunction: causes, prevalence, diagnosis, and treatment options.
- NIMH - Mental Illness StatisticsNIMH data: 1 in 5 U.S. adults experience mental illness annually. National prevalence by condition, age, and demographic.
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards



